Multidisciplinary International Group for Hemapheresis TherapY and MEtabolic DIsturbances Contrast
Benvenuti nel sito web di MIGHTY MEDIC, il Gruppo Multidisciplinare dedicato alle terapie aferetiche nell’ambito delle patologie metaboliche ed alla loro applicazione in combinazione con i farmaci di ultima generazione.
Welcome into the web site of MIGHTY MEDIC, the Multidisciplinary Group dedicated to apheresis therapies for the treatment of metabolic pathologies and their application in combination with last-generation drugs.
MULTIDISCIPLINARY INTERNATIONAL GROUP FOR HEMAPHERESIS THERAPY AND METABOLIC DISTURBANCES CONTRAST
Utilising Recent Advances to Identify and Address Unmet Clinical Needs Register Now > Agenda > Date: 9th December 2024 – 10th December 2024 Venue: DoubleTree by Hilton, Manchester Airport (International Hybrid Event) Organisers: Professor Handrean Soran & Dr Maryam Ferdousi This meeting is for health care professionals and it is not open for …
MIGHTY MEDIC Org.’s Advanced Clinical Major Seminary and Educational Forum on Clinical Lipidology, Metabolic Disorders, Extracorporeal Therapeutic Techniques, and Atherosclerosis Prevention Seminario Clinico Avanzato e formazione continua in Lipidologia Clinica, Disturbi del Metabolismo, Tecniche Terapeutiche Extracorporee e Prevenzione dell’Aterosclerosi Peschiera del Garda, Italy, April 18-19, 2024 FINAL PROGRAM
There is a new reality in Italy that is likely to affect all of Europe, as was the case with Lomitapide. “Evinacumab is reimbursed as an adjunct to diet and other therapies aimed at reducing low-density lipoprotein cholesterol (LDL-C) for the treatment of adult and adolescent patients aged 12 years …
1st ILEP (International Lipid Expert Panel) virtual symposium on cardiovascular prevention will be held on March 19th, 2022. Symposium Chairman: Prof. Maciej Banach Visit ILEP web site at: https://ilep.eu/ Program
PICTURES OF THE EVENT October 7-8, 2021 – Verona 16th LIPID CLUB AND THERAPEUTIC APHERESIS Seminary and Educational Forum on Clinical Lipidology, Metabolic Disorders, Extracorporeal Therapeutic Techniques, and Atherosclerosis Prevention Verona, October 7-8, 2021Camera di Commercio, Industria Artigianato e Aricoltura di Verona Corso Porta Nuova, 96 – 37122 Verona VR …
We are collecting anonymised information on patients with familial chylomicronaemia syndrome (FCS)/multifactorial chylomicronaemia syndrome (MCS) as a service evaluation & quality improvement project. The project aims to improve understanding of natural history of FCS and to validate the use of FCS scoring algorithm. The project is approved by Manchester University …
3rd Congress of the European Group – International Society for Apheresis (E-ISFA) Dresden, March 19 to 21, 2020 Congress Topics Recent progress in lipoprotein apheresis Homozygous familial hypercholesterolemia Lipoprotein(a) Competition with drugs Plasma exchange Immunoadsorption – indications, results, future perspectives Experience with extracorporeal therapy in children and during pregnancy Apheresis Registries …
14th Lipid Club and Therapeutic Apheresis 2019 Udine, May 30-31 2019 ADVANCED COURSE ON CLINICAL LIPIDOLOGY, METABOLIC DISORDERS AND THERAPEUTIC APHERESIS FINAL PROGRAM
The brochure on Familiar Hypercholsterolemia from Nutritional Medicine Institute of Austrian Academy (in German) Die Broschüre über familiäre Hypercholesterinämie von Österreichisches Akademisches Institut für Ernährungsmedizin (ÖAIE)
Cardiology Update Davos, Switzerland 16-20 February 2019 Dear Colleagues It is my pleasure to announce the next Cardiology Update Course in Davos which belongs to the major meetings in the field of cardiology in Europe. As you know it is an Update Meeting endorsed by the ESC and a collaboration …
Prof. Gerald Watts: Prof. Claudia Stefanutti Prof. Livia Pisciotta Prof. Widhalm
Streaming – Part 1 Streaming – Part 2
13th LipidClub and Therapeutic Apheresis Program: LIPID-2018-final-program-10_04.pdf Registration form: Scheda LIPID 2018
23 Annual Meeting of the Israeli Society for Research, Prevention and Treatment of Atherosclerosis
May 3-4 2017, Istituto Salesiano Sacro Cuore, Rome Final Program PRESENTATIONS
LIPIDOLOGY AND ATHEROSCLEROSIS WORKSHOP European Society for Clinical Investigation May 17th, 2017 Preliminary program
Cholesterol – A Problem Solved? HEART UK 31st Annual Medical & Scientific Conference Wednesday 5 – Friday 7 July 2017 Warwick Arts Centre, University of Warwick, Coventry CV4 7AL Conference website Register
The MIGHTY MEDIC Org FALL SCHOOL of CLINICAL LIPIDOLOGY October, 4, 2016
X Congresso Aferesi Terapeutica del Gruppo di Studio della Società Italiana di Nefrologia Napoli, 4 – 5 Novembre 2016 Centro Congressi Via Partenope
NOVEMBER 11-12, 2016 VIENNA, AUSTRIA
OBJECTIVE: Lomitapide (a microsomal triglyceride transfer protein inhibitor) is an adjunctive treatment for homozygous familial hypercholesterolaemia (HoFH), a rare genetic condition characterised by elevated low-density lipoprotein-cholesterol (LDL-C), and premature, severe, accelerated atherosclerosis. Standard of care for HoFH includes lipid-lowering drugs and lipoprotein apheresis. We conducted a post-hoc analysis using data …
